Literature DB >> 8415555

Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities.

M S Chowdhury1, A el Harith, A al Massum, E al Karim, A al Rahman.   

Abstract

Control of endemic visceral leishmaniasis (VL) in large communities requires a feasible epidemiological indicator capable of monitoring on-going transmission rather than mere exposure to the parasite. Following confirmation of the desired level of reliability for laboratory diagnosis of VL, the direct agglutination test (DAT) was employed to estimate VL sero-prevalence in the endemic upazilas (subdistricts) of Trishal and Shahjadpur within Mymensingh and Sirajganj districts of Bangladesh. DAT antigen production was duly increased to allow coverage of a study population of 17826 inhabitants, 9619 of whom resided in Trishal, 7328 in Shahjadpur and 879 in Teknaf (Cox's Bazar), a known Leishmania-free district in Bangladesh. Despite large-scale production in batches of 1120-4000 ml (each sufficient for 1176-6400 screening doses), all DAT antigen batches performed as required in quality control tests for sensitivity, specificity and stability. It was convenient for both collection and testing to take the required samples of whole blood by finger prick. A cross-sectional survey revealed VL point prevalences of 4.40% in Trishal and 6.75% in Shahjadpur, compared with an extremely low rate of 0.34% in non-endemic Teknaf. In both endemic upazilas (Trishal and Shahjadpur) VL was more prevalent (2.56-4.5%) in persons up to 20 years of age than in those 21 years of age and older (1.84-2.25%). Of 918 subjects recorded as seropositives, 539 were VL-asymptomatic and 379 were VL-symptomatic with various degrees of suspicion. Diagnosis of VL was established in 125 symptomatic seropositives subjects, either by demonstrating the presence of Leishmania amastigotes (29), or by positive DAT results combined with presentation of typical VL signs (96).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415555     DOI: 10.1007/bf00931580

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  16 in total

1.  Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India.

Authors:  A Choudhry; P Y Guru; R P Saxena; A Tandon; K C Saxena
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

2.  Visceral leishmaniasis and its control in Bangladesh.

Authors:  M Elias; A J Rahman; N I Khan
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

3.  Positive response to sodium antimony gluconate administration in visceral leishmaniasis seropositive patients.

Authors:  S Chowdhury; F Haque; A al-Masum; A el Harith; E Karim
Journal:  Am J Trop Med Hyg       Date:  1991-04       Impact factor: 2.345

4.  A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis.

Authors:  A E Harith; A H Kolk; P A Kager; J Leeuwenburg; R Muigai; S Kiugu; S Kiugu; J J Laarman
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

5.  Introduction of an improved direct agglutination test for the detection of Leishmania infantum infection in southern France.

Authors:  P M de Korte; A E Harith; J Dereure; E Huigen; V Faucherre; H J van der Kaay
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.

Authors:  P C Sen Gupta; A M Mukherjee
Journal:  J Indian Med Assoc       Date:  1968-01-01

7.  Visceral leishmaniasis in southern Sudan.

Authors:  W A Perea; T Ancelle; A Moren; M Nagelkerke; E Sondorp
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jan-Feb       Impact factor: 2.184

8.  The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia.

Authors:  G Mengistu; R Kiessling; H Akuffo
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 May-Jun       Impact factor: 2.184

9.  Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib; P A Kager
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

10.  A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis.

Authors:  P de Beer; A el Harith; L L Deng; S J Semiao-Santos; B Chantal; M van Grootheest
Journal:  Am J Trop Med Hyg       Date:  1991-03       Impact factor: 2.345

View more
  11 in total

1.  Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis.

Authors:  Radheshyam Maurya; Sanjana Mehrotra; Vijay Kumar Prajapati; Susanne Nylén; David Sacks; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

2.  Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis.

Authors:  Israel Cruz; Carmen Chicharro; Javier Nieto; Begoña Bailo; Carmen Cañavate; María-Concepción Figueras; Jorge Alvar
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.

Authors:  K M Kurkjian; L E Vaz; R Haque; C Cetre-Sossah; S Akhter; S Roy; F Steurer; J Amann; M Ali; R Chowdhury; Y Wagatsuma; J Williamson; S Crawford; R F Breiman; J H Maguire; C Bern; W E Secor
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

4.  Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

Authors:  A el Harith; S Chowdhury; A al-Masum; S Semião-Santos; E Karim; S el-Safi; I Haque
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

5.  Diagnosis of visceral leishmaniasis by enzyme-linked immunosorbent assay using urine samples.

Authors:  Mohammad Zahidul Islam; Makoto Itoh; S M Shamsuzzaman; Rusella Mirza; Farzana Matin; Iftikhar Ahmed; A K M Shamsuzzaman Choudhury; M Akram Hossain; Xu-Guang Qiu; Nilufar Begam; Masato Furuya; Judson L Leafasia; Yoshihisa Hashiguchi; Eisaku Kimura
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis.

Authors:  C Fargeas; M Hommel; R Maingon; C Dourado; M Monsigny; R Mayer
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial.

Authors:  Albert Picado; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Bart Ostyn; François Chappuis; Surendra Uranw; Kamlesh Gidwani; Basudha Khanal; Madhukar Rai; Ishwari Sharma Paudel; Murari Lal Das; Rajiv Kumar; Pankaj Srivastava; Jean Claude Dujardin; Veerle Vanlerberghe; Elisabeth Wreford Andersen; Clive Richard Davies; Marleen Boelaert
Journal:  BMJ       Date:  2010-12-29

8.  Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Authors:  Bart Ostyn; Kamlesh Gidwani; Basudha Khanal; Albert Picado; François Chappuis; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

9.  Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India.

Authors:  Pabitra Saha; Swagata Ganguly; Moytrey Chatterjee; Soumendu Bikash Das; Pratip K Kundu; Subhasish K Guha; Tamal K Ghosh; Dilip K Bera; Nandita Basu; Ardhendu K Maji
Journal:  PLoS Negl Trop Dis       Date:  2017-02-10

Review 10.  Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.

Authors:  Siddhivinayak Hirve; Marleen Boelaert; Greg Matlashewski; Dinesh Mondal; Byron Arana; Axel Kroeger; Piero Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2016-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.